KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Receivables (2016 - 2025)

Precigen (PGEN) has disclosed Receivables for 14 consecutive years, with $4.4 million as the latest value for Q4 2025.

  • Quarterly Receivables rose 275.06% to $4.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2025, up 275.06% year-over-year, with the annual reading at $4.4 million for FY2025, 275.06% up from the prior year.
  • Receivables for Q4 2025 was $4.4 million at Precigen, up from $1.1 million in the prior quarter.
  • The five-year high for Receivables was $26.6 million in Q2 2021, with the low at $479000.0 in Q3 2024.
  • Average Receivables over 5 years is $8.3 million, with a median of $1.7 million recorded in 2021.
  • The sharpest move saw Receivables soared 6713.13% in 2021, then tumbled 96.47% in 2024.
  • Over 5 years, Receivables stood at $1.9 million in 2021, then soared by 602.1% to $13.4 million in 2022, then crashed by 88.24% to $1.6 million in 2023, then dropped by 26.16% to $1.2 million in 2024, then soared by 275.06% to $4.4 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $4.4 million, $1.1 million, and $571000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.